No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹14.7Prev. Close
₹14.79Turnover(Lac.)
₹2.27Day's High
₹14.71Day's Low
₹14.1152 Week's High
₹19.952 Week's Low
₹9.64Book Value
₹1.53Face Value
₹10Mkt Cap (₹ Cr.)
11.96P/E
0EPS
0Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 8.13 | 8.13 | 8.13 | 8.13 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -6.15 | -5.31 | 2.73 | 2.83 |
Net Worth | 1.98 | 2.82 | 10.86 | 10.96 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 8.16 | 197.39 | 79.71 | 61.88 |
yoy growth (%) | -95.86 | 147.63 | 28.8 | -1.67 |
Raw materials | -3.95 | -154.62 | -57.59 | -40.72 |
As % of sales | 48.36 | 78.33 | 72.24 | 65.8 |
Employee costs | -1.05 | -5.35 | -3.32 | -3.34 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 0.13 | 0.71 | 0.68 | 1.13 |
Depreciation | -0.28 | -1.95 | -1.68 | -1.7 |
Tax paid | 0.8 | -1.28 | 0 | -0.62 |
Working capital | -19.52 | -3.33 | 2.94 | 3.15 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -95.86 | 147.63 | 28.8 | -1.67 |
Op profit growth | -78.18 | 5.72 | -0.76 | -7.62 |
EBIT growth | -74.28 | -5.76 | 2.65 | -15.72 |
Net profit growth | -267.66 | -183.02 | 34.97 | -39.65 |
| Particulars (Rupees in Crores.) | Mar-2012 |
|---|---|
Gross Sales | 78.91 |
Excise Duty | 0 |
Net Sales | 78.91 |
Other Operating Income | 6.88 |
Other Income | 0.25 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,753.3 | 96.36 | 4,20,555.43 | 705.44 | 0.91 | 5,651.21 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,026 | 62.15 | 1,59,889.07 | 598 | 0.5 | 2,578 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,256.6 | 64.51 | 1,44,072.84 | 577 | 0.14 | 2,547 | 249.82 |
Lupin Ltd LUPIN | 2,331.8 | 19.27 | 1,06,571.05 | 717.45 | 0.51 | 4,433.96 | 595.67 |
Dr Reddys Laboratories Ltd DRREDDY | 1,259.6 | 22.66 | 1,05,132.93 | 90.6 | 0.63 | 4,266.4 | 377.55 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
S Murali Krishna Murthy
Non Executive Director
Pramod Dnyandeo Wag He
Independent Director
Mounika Pammi
Whole-time Director
Prashant Prakash Sawant
Whole-time Director
Prakruti Prakash Sawant
Chairman & Independent Directo
Sarang Balbhimrao Patodekar
Independent Director
Ajay Vishwakarma
Company Sec. & Compli. Officer
Madhu Solanki
D No 1-8-B4 Ground Floor F3,
HIG Block-4 Street No 3,
Telangana - 500044
Tel: -
Website: http://www.ortinlabsindia.com
Email: info@ortinlabsindia.com
Karvy Selenium Tow-B,
31&32 Financial Dist, Nanakramguda,
Hyderabad-500032
Tel: 91-40-67162222
Website: www.kfintech.com
Email: einward.ris@karvy.com
Summary
Ortin Global Limited was initially incorporated as Ortin Laboratories Limited in October 1986 to offer quality Drugs and Medicines to the suffering mankind. Name of the Company was changed from Ortin...
Read More
Reports by Ortin Laboratories Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.